P2RX7 and cancer: Hence, we suggest a more promising cancer target, P2X7, as the upstream component of a tumoricidal ATP signal transduction network in that activation of it leads to concurrent and efficacious blockade of both PI3K/AKT and mTOR pathways, without affecting escape mechanisms as those often seen with rapalogs nor PTEN expression (data not shown).